Smoking cessation

From Citizendium
Revision as of 16:03, 23 December 2007 by imported>Joe Quick (subpages)
Jump to navigation Jump to search
This article is a stub and thus not approved.
 Main Article
 Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
https://en.citizendium.org/wiki/index.php?title=Smoking_cessation&printable=yes
This editable Main Article is under development and subject to a disclaimer.

Medications

Rimonabant

Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a meta-analysis of randomized controlled trials by the Cochrane Collaboration.[1] However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."[1]

References

  1. ↑ 1.0 1.1 Cahill K, Ussher M (2007). "Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation". Cochrane Database Syst Rev (4): CD005353. DOI:10.1002/14651858.CD005353.pub3. PMID 17943852. Research Blogging.
Retrieved from "https://citizendium.org/wiki/index.php?title=Smoking_cessation&oldid=357067"